A041830 Share Price Performance
Recent A041830 News & Updates
No updates
InBody Co.,Ltd Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 2.47k
- Gross Margin
- 77.03%
- Net Profit Margin
- 14.81%
- Debt/Equity Ratio
- 0%
InBody Co.,Ltd Competitors
About A041830
- Founded
- 1996
- Employees
- 312
- CEO
- WebsiteView website
InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in bariatric, cardiology, diabetes, frailty and aging, ICU, lymphedema, nephrology, nutrition, oncology, sports medicine, and rehabilitation and physical therapy applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.
South Korean Market Performance
- 7 Days: 1.5%
- 3 Months: 24.6%
- 1 Year: 13.5%
- Year to Date: 32.5%
The market is up 1.5% over the last week, with the Information Technology sector leading the way, up 5.3%. In the last year, the market has climbed 14%. Earnings are forecast to grow by 21% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading